Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.060
-0.010 (-0.93%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Lisata Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.44 | 15.96 | 16.21 | 22.59 | 32.15 | 24.65 |
Short-Term Investments | - | - | 15.04 | 27.94 | 37.07 | 70.32 |
Cash & Short-Term Investments | 10.44 | 15.96 | 31.25 | 50.54 | 69.23 | 94.97 |
Cash Growth | -52.47% | -48.93% | -38.17% | -27.00% | -27.11% | 174.69% |
Accounts Receivable | - | - | 0.9 | - | - | - |
Other Current Assets | 0.57 | 1.75 | 2.43 | 3.39 | 2.65 | 1.21 |
Total Current Assets | 11.01 | 17.7 | 34.58 | 53.92 | 71.88 | 96.18 |
Net Property, Plant & Equipment | 0.01 | 0.02 | 0.07 | 0.18 | 0.3 | 0.06 |
Other Intangible Assets | - | - | 0.19 | 0.26 | 0.33 | - |
Other Long-Term Assets | - | 0.02 | 0.16 | 0.33 | 0.53 | 0.76 |
Total Assets | 11.03 | 17.74 | 35 | 54.69 | 73.03 | 97.01 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.84 | 1.02 | 1.28 | 2.42 | 2.66 | 1.93 |
Accrued Expenses | 2.15 | 2.05 | 4.33 | 4.17 | 3.73 | 2.59 |
Total Current Liabilities | 2.99 | 3.07 | 5.61 | 6.59 | 6.38 | 4.52 |
Other Long-Term Liabilities | 0.05 | 0.07 | 0.07 | 0.21 | 0.33 | 0.49 |
Total Long-Term Liabilities | 0.05 | 0.07 | 0.07 | 0.21 | 0.33 | 0.49 |
Total Liabilities | 3.04 | 3.14 | 5.69 | 6.8 | 6.71 | 5.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Treasury Stock | -0.71 | -0.71 | -0.71 | -0.71 | -0.71 | -0.71 |
Additional Paid-in Capital | 581.03 | 580.24 | 578.42 | 576.97 | 574.55 | 546.04 |
Accumulated Other Comprehensive Income | -0.02 | -0.04 | -0.08 | -0.04 | -0.03 | -0.07 |
Retained Earnings | -572.07 | -564.65 | -548.07 | -528.08 | -507.24 | -453.02 |
Total Common Shareholders' Equity | 8.24 | 14.86 | 29.57 | 48.15 | 66.58 | 92.25 |
Minority Interest | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 | -0.25 |
Shareholders' Equity | 7.99 | 14.6 | 29.32 | 47.89 | 66.32 | 92 |
Total Liabilities & Equity | 11.03 | 17.74 | 35 | 54.69 | 73.03 | 97.01 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 10.44 | 15.96 | 31.25 | 50.54 | 69.23 | 94.97 |
Net Cash Growth | -52.47% | -48.93% | -38.17% | -27.00% | -27.11% | 174.69% |
Net Cash Per Share | 1.17 | 1.84 | 3.75 | 6.26 | 13.36 | 25.75 |
Book Value | 8.24 | 14.86 | 29.57 | 48.15 | 66.58 | 92.25 |
Book Value Per Share | 0.92 | 1.71 | 3.55 | 5.96 | 12.85 | 25.01 |
Tangible Book Value | 8.24 | 14.86 | 29.38 | 47.89 | 66.24 | 92.25 |
Tangible Book Value Per Share | 0.92 | 1.71 | 3.53 | 5.93 | 12.79 | 25.01 |